These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1720122)

  • 1. Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface.
    Lakkakorpi PT; Horton MA; Helfrich MH; Karhukorpi EK; Väänänen HK
    J Cell Biol; 1991 Nov; 115(4):1179-86. PubMed ID: 1720122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy.
    Lakkakorpi PT; Helfrich MH; Horton MA; Väänänen HK
    J Cell Sci; 1993 Mar; 104 ( Pt 3)():663-70. PubMed ID: 7686168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
    Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
    J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin--a possible anchor of osteoclasts to bone.
    Reinholt FP; Hultenby K; Oldberg A; Heinegård D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4473-5. PubMed ID: 1693772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
    Horton MA; Taylor ML; Arnett TR; Helfrich MH
    Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organization of osteoclast microfilaments during the attachment to bone surface in vitro.
    Lakkakorpi P; Tuukkanen J; Hentunen T; Järvelin K; Väänänen K
    J Bone Miner Res; 1989 Dec; 4(6):817-25. PubMed ID: 2692403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.
    Helfrich MH; Nesbitt SA; Lakkakorpi PT; Barnes MJ; Bodary SC; Shankar G; Mason WT; Mendrick DL; Väänänen HK; Horton MA
    Bone; 1996 Oct; 19(4):317-28. PubMed ID: 8894137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
    Duong LT; Rodan GA
    Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies.
    Mattsson JP; Skyman C; Palokangas H; Väänänen KH; Keeling DJ
    J Bone Miner Res; 1997 May; 12(5):753-60. PubMed ID: 9144341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone sialoprotein stimulates in vitro bone resorption.
    Raynal C; Delmas PD; Chenu C
    Endocrinology; 1996 Jun; 137(6):2347-54. PubMed ID: 8641185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
    Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
    Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation.
    Ilvesaro JM; Lakkakorpi PT; Väänänen HK
    Exp Cell Res; 1998 Jul; 242(1):75-83. PubMed ID: 9665804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
    Dresner-Pollak R; Rosenblatt M
    J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone is not essential for osteoclast activation.
    Fuller K; Ross JL; Szewczyk KA; Moss R; Chambers TJ
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks.
    Okumura S; Mizoguchi T; Sato N; Yamaki M; Kobayashi Y; Yamauchi H; Ozawa H; Udagawa N; Takahashi N
    Bone; 2006 Oct; 39(4):684-93. PubMed ID: 16774853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate disturbs vesicular trafficking in osteoclasts.
    Alakangas A; Selander K; Mulari M; Halleen J; Lehenkari P; Mönkkönen J; Salo J; Väänänen K
    Calcif Tissue Int; 2002 Jan; 70(1):40-7. PubMed ID: 11907706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podosome and sealing zone: specificity of the osteoclast model.
    Jurdic P; Saltel F; Chabadel A; Destaing O
    Eur J Cell Biol; 2006 Apr; 85(3-4):195-202. PubMed ID: 16546562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of osteoclast polarization.
    Takahashi N; Ejiri S; Yanagisawa S; Ozawa H
    Odontology; 2007 Jul; 95(1):1-9. PubMed ID: 17660975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeletal changes in osteoclasts during the resorption cycle.
    Lakkakorpi PT; Väänänen HK
    Microsc Res Tech; 1996 Feb; 33(2):171-81. PubMed ID: 8845516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.